Table 2.
Demographic and laboratory characteristics of the confirmed and suspected COVID‐19 patient groups
| Variables | Confirmed COVID‐19 patients | Suspected COVID‐19 patients | p Value |
|---|---|---|---|
| Patients, n | 251 | 65 | |
| Age, years, (mean ± SD) | 8.92 ± 6.01 | 3.60 ± 4.51 | <.001 |
| Gender, male, n (%) | 139 (55.4) | 36 (55.4) | .999 |
| Laboratory findings | |||
| MPV (mean ± SD), fL | 9.93 ± 1.04 | 10.0 ± 0.91 | .894 |
| PLT (mean ± SD)/mm3 | 283,565 ± 77,434 | 338,823 ± 93,611 | <.001 |
| WBC (mean ± SD)/mm3 | 10,067 ± 5841 | 13,092 ± 6465 | <.001 |
| ANC (mean ± SD)/mm3 | 6139 ± 5527 | 6322 ± 3889 | <.001 |
| ALC (mean ± SD)/mm3 | 2825 ± 2254 | 4932 ± 3771 | <.001 |
| Hb (mean ± SD), g/dL | 12.5 ± 1.84 | 11.3 ± 1.74 | <.001 |
| CRP (mean ± SD), mg/L | 30.1 ± 47.2 | 36.6 ± 35.6 | <.001 |
| PCT (mean ± SD), µg/L | 0.84 ± 2.18 | 3.19 ± 11.7 | <.001 |
| D‐dimer (mean ± SD), µg/L | 1434 ± 1337 | 989 ± 814 | .179 |
| Fibrinogen (mean ± SD), mg/dl | 352 ± 126 | 401 ± 92.3 | <.001 |
| NT‐pro‐BNP (mean ± SD), ng/L | 186.7 ± 411.3 | 824 ± 1531 | <.001 |
| Lymphopenia n (%) | 65 (25.9) | 4 (6.2) | <.001 |
| (<1500/mm3) | |||
| Neutropenia, n (%) | 36 (14.3) | 1 (1.5) | .002 |
| (<1500/mm3) | |||
| Thrombocytopenia, n (%) | 11 (4.4) | 0 (0) | .129 |
| (<150,000/mm3) | |||
| NLR (mean ± SD) | 4.71 ± 6.31 | 3.4 ± 5.38 | .159 |
| Increased CRP, n (%) | 94 (37.5) | 47 (72.3) | <.001 |
| (>5 mg/L) | |||
| Increased Procalcitonin | 176 (70.1) | 27 (41.5) | <.001 |
| (>0.5) µg/L |
Note: The bold values indicate statistical analysis differences and correlations were considered significant at p < .05.
Abbreviations: ALC, absolute lymphocyte count; ANC, absolute neutrophil count; COVID‐19, coronavirus disease 2019; CRP, C‐reactive protein; Hb, hemoglobin; MPV, mean platelet volume; NLR, neutrophil‐to‐lymphocyte ratio; NT‐pro‐BNP, N‐terminal‐pro‐brain natriuretic peptide; PCT, procalcitonin; PLT, platelet count; WBC, white blood cell.